- Leading market position maintained and strenghened – Quality Matters!
- Sales growth of 12% in second semester compared to first half of 2010 (at comparable exchange rates)
- Full year EBIT more than tripled versus first semester of 2010 (before special items and at comparable exchange rates)
- Pipeline expanded thanks to the successful acquisition of new projects
- Sustainable annual cost savings of 5.8 million CHF achieved
- Reorganization in North America completed; non-GMP custom synthesis now handled by Bachem competence center in the UK
- Attractive dividend of CHF 2.50 proposed